Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-014726
Filing Date
2025-03-25
Accepted
2025-03-25 16:16:49
Documents
1
Period of Report
2025-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1742933802.html 4  
1 FORM 4 wk-form4_1742933802.xml 4 8717
  Complete submission text file 0001628280-25-014726.txt   10119
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address
Muzzey Dale (Reporting) CIK: 0001922964 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 25768514